BALDESCHI, LELIO
 Distribuzione geografica
Continente #
NA - Nord America 6.944
AS - Asia 3.764
EU - Europa 2.850
SA - Sud America 565
AF - Africa 143
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.281
Nazione #
US - Stati Uniti d'America 6.599
CN - Cina 1.107
IT - Italia 1.049
SG - Singapore 936
HK - Hong Kong 681
BR - Brasile 453
SE - Svezia 399
BG - Bulgaria 285
UA - Ucraina 252
CA - Canada 235
DE - Germania 225
TR - Turchia 193
KR - Corea 172
VN - Vietnam 150
GB - Regno Unito 128
IN - India 125
FI - Finlandia 118
RU - Federazione Russa 113
CH - Svizzera 112
BD - Bangladesh 90
IQ - Iraq 54
FR - Francia 51
JP - Giappone 46
SA - Arabia Saudita 34
ID - Indonesia 30
AR - Argentina 29
NL - Olanda 29
CI - Costa d'Avorio 28
MX - Messico 28
PK - Pakistan 27
VE - Venezuela 24
ZA - Sudafrica 22
KE - Kenya 21
UZ - Uzbekistan 19
JM - Giamaica 17
MA - Marocco 17
AT - Austria 16
BB - Barbados 16
BE - Belgio 16
EC - Ecuador 14
JO - Giordania 12
NP - Nepal 12
PL - Polonia 11
CO - Colombia 10
EG - Egitto 10
IL - Israele 10
SN - Senegal 10
TT - Trinidad e Tobago 10
ES - Italia 9
GR - Grecia 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
HN - Honduras 7
KZ - Kazakistan 7
PA - Panama 7
TN - Tunisia 7
UY - Uruguay 7
CL - Cile 6
ET - Etiopia 6
IE - Irlanda 6
PY - Paraguay 6
AL - Albania 5
BJ - Benin 5
BO - Bolivia 5
CR - Costa Rica 5
OM - Oman 5
PE - Perù 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
IR - Iran 4
LB - Libano 4
NG - Nigeria 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AO - Angola 3
GE - Georgia 3
GY - Guiana 3
KW - Kuwait 3
LK - Sri Lanka 3
MY - Malesia 3
NI - Nicaragua 3
PH - Filippine 3
PT - Portogallo 3
QA - Qatar 3
SR - Suriname 3
BH - Bahrain 2
CY - Cipro 2
EU - Europa 2
GD - Grenada 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
KY - Cayman, isole 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SX - ???statistics.table.value.countryCode.SX??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 14.259
Città #
Woodbridge 809
Hong Kong 674
Ashburn 624
Ann Arbor 541
Houston 533
Santa Clara 507
Milan 506
Singapore 504
Fairfield 450
Chandler 405
Jacksonville 352
Sofia 283
Shanghai 236
Ottawa 208
Beijing 207
Hefei 191
Seattle 191
Dallas 185
New York 182
Wilmington 173
Seoul 164
Cambridge 141
Boardman 126
Nanjing 123
Izmir 122
Los Angeles 119
Princeton 115
Bern 111
Lawrence 111
Medford 99
Florence 89
Dearborn 64
Jüchen 61
Serra 61
Des Moines 55
Nanchang 53
Istanbul 48
Dong Ket 45
Buffalo 42
Redondo Beach 39
Rome 39
Kunming 37
Tokyo 36
Ogden 29
Abidjan 28
Munich 26
Hebei 25
Dhaka 22
São Paulo 22
Ho Chi Minh City 21
San Diego 21
Washington 21
Shenyang 20
Hangzhou 17
Bridgetown 16
Nairobi 16
Baghdad 15
Riyadh 15
Tashkent 15
Frankfurt am Main 14
Hanoi 14
Orange 14
Kingston 13
Lancaster 13
London 13
Norwalk 13
Rio de Janeiro 13
Changsha 12
Guangzhou 12
Jeddah 12
Jiaxing 12
Vienna 12
Amman 11
Boulder 11
Pune 11
Belo Horizonte 10
Dakar 10
Redwood City 10
Tianjin 10
Campinas 9
Council Bluffs 8
Johannesburg 8
Osaka 8
Cairo 7
Caracas 7
Delhi 7
Falkenstein 7
Kathmandu 7
Maracaibo 7
Mumbai 7
San Jose 7
Amsterdam 6
Anderlecht 6
Brasília 6
Goiânia 6
Jinan 6
Karachi 6
Lanzhou 6
Najaf 6
Panama City 6
Totale 10.373
Nome #
Correction of lid retraction and exophthalmos. 201
Re: Orbitozygomatic approach for excisions of orbital tumors with 1 piece of craniotomy bone flap: 2 case reports by Chi-Wen Chang et al. Surg Neurol 2007;68(SI):58. 195
Is sleeping position related to asymmetry in bilateral Graves' ophthalmopathy? 194
Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. 187
Re: "thyroid eye disease presenting after cosmetic botulinum toxin injections". 178
A new and validated CT-based method for the calculation of orbital soft tissue volumes. 178
Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves' ophthalmopathy. 175
Small versus coronal incision orbital decompression in Graves' orbitopathy. 175
A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. 173
The intranasal ostium after external dacryocystorhinostomy and the internal opening of the lacrimal canaliculi. 173
Glass ionomer implants and tissue aluminum levels: an animal study. 172
Correction of lid retraction and exophthalmos. 171
Somatostatin receptor scintigraphy for optic nerve sheath meningiomas. 170
The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy. 166
Brachytherapy as part of the multidisciplinary treatment of childhood rhabdomyosarcomas of the orbit. 163
Management of Graves’ orbitopathy in Europe: a questionnaire survey conducted by the European Group on Graves Orbitopathy (EU.GO.GO). 162
Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy 161
Vitreal and serum growth hormone in proliferative diabetic retinopathy, diabetic retinopathy and in control subjects. 160
Studio delle vie lacrimali con dacriocistografia digitale. [Study of lacrimal system using digital dacryocystography]. 158
Chirurgia della cataratta in presenza di tamponamento interno con olio di silicone. [Cataract surgery with silicon oil in posterior chamber]. 157
Uso dell'olio di silicone nel trattamento chirurgico della retinopatia diabetica proliferante: nostra casistica. [Silicon oil in surgical treatment of proliferative diabetic retinopathy: our experience]. 156
The length of unsutured mucosal margins in external dacryocystorhinostomy. 154
Supernumerary extraocular muscle in Graves' orbitopathy. 154
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. 153
Rehabilitative surgery. 153
Small versus coronal incision orbital decompression in Graves' orbitopathy. 151
TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. 150
Unilateral Graves’ orbitopathy: a case control and retrospective follow up study. 149
Age and gender-specific reference values of orbital fat and muscle volumes in Caucasians. 149
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. 148
Traumatic neuroma of the infraorbital nerve subsequent to inferomedial orbital decompression for Graves' orbitopathy. 147
Effetto di colliri antinfiammatori steroidei e non steroidei sulle variazioni dell'astigmatismo corneale dopo estrazione extracapsulare di cataratta. [Effect of steroid and not-steroid anti-inflammatory eye drops on variations of corneal astigmatism after extra capsular cataract extraction]. 146
Cosa aspettarsi dalla chirurgia decompressiva a tre pareti in caso di orbitopatia distiroidea non complicata da diplopia pre operatoria: Uno studio retrospettivo su 134 pazienti. (What is to be expected by three wall decompression surgery performed on patients affected by dysthyroid orbitopathy without pre operative double vision). 146
Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy. 146
What should patients with Graves’ orbitopathy without functional deficit should expect from decompression surgery. 145
Orbital decompression. 145
Intranasal ostium after external dacryocystorhinostomy and internal opening of the lacrimal canaliculi. 144
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 142
Selenium and the course of mild Graves' Orbitopathy 141
Graves’ orbitopathy: transmission via bone marrow transplantation? 140
Orbital decompressions: status of the art and unresolved issues. 140
Future developments. 140
Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association. 140
Reactivation of Graves’ orbitopathy after aesthetic orbital decompression. 139
The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. 139
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. 137
A comparison for skin storage methods for oculoplastic surgery 137
Orbital venous anomalies. 136
Efficacy and safety of three different cumulative doses of intraveneous methylprednisolone for moderate to severe and active Graves’ orbitopathy. 136
Sensitivity and specificity of ultrasonography, fluorescein videoangiography, indocyanine green videoangiography, magnetic resonance and radioimmunoscintigraphy in the diagnosis of primary choroidal malignant melanoma. 136
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey 135
GH vitreale e sierico nella RDP e in soggetti normali. [Vitreal and serum growth hormone in proliferative diabetic retinopathy and in control subject]. 133
Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients. 133
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience 133
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 133
A questionnaire survey on the management of Graves' orbitopathy in Europe 132
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. 132
Suture regolabili nel trattamento chirurgico della retrazione della palpebra superiore nell'oftalmopatia Basedowiana: nostra casistica. [Adjustables suture for the correction of upper eyelid retraction in Basedow’s ophthalmopathy: our experience]. 130
Effectiveness of early versus late orbital decompression in thyroid related orbitopathy. 130
Anterior suspended flaps: a modified approach for external dacryocystorhinostomy 129
Does orbital radiotherapy influence the effect of orbital decompression in Graves’ orbitopathy. 127
Optimising the Rotterdam Fasciatome and Fascia Splitter. 126
The contribution of the deep lateral wall to orbital decompression in thyroid related orbitopathy. 124
Damage of foldable intraocular lenses by incorrect folder forceps 124
Trattamento con suture aggiustabili della retrazione palpebrale superiore in corso di oftalmopatia basedowiana 123
Orbital decompression. 122
Surgical decompression in thyroid eye disease: does the approach matter? 121
Il trattamento chirurgico del pucker maculare. [Surgical treatment of macular pucker]. 120
Langzeitergebnisse sekundärer orbitaimplantate (Long-term results of secondary orbital implant). 119
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. 119
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. 119
Distacco di retina nello pseudofachico. [Retinal detachment in pseudophachic patients]. 118
Ocular adnexal lymphomas. 118
Rehabilitative surgery. 118
Test-retest reliability and responsiveness of the GO-QOL; a disease-specific quality of life questionnaire for patients with Graves’ ophthalmopathy. 118
Sequelae to secondary orbital implant. 117
E.E.C. syndrome: a rare disease with lacrimal drainage disorders. 117
Intervento modificato di dacriocistorinostomia. [Modified dacryocystorhinostomy]. 112
Bony orbital development after early enucleation in humans. 111
Future developments. 110
Drie gevallen van zeldzame metastase naar oog en orbita (Three cases of unusual metastasis to eye and orbit). 109
Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures. 108
Age- and gender related differences in orbital soft tissue volumes unravelled. 108
Suture-less trans-fornix approach for infero-medial decompression in dysthyroid orbitopathy. 107
Ultrasonographic and angiographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy. 107
Long-term results of secondary orbital implants. 104
Upper eyelid lengthening in Graves’ ophthalmopathy. 104
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. 104
Orbital decompresssion in Graves' orbitopathy: state of the art and novel perspectives. 103
A case of a late complication after naso-iacrimal duct intubation 101
Functional and rehabilitative surgery of Graves’ orbitopathy. 100
Evaluation of aesthetic rehabilitation of patients with congenital microphthalmos. 99
Een suspect aspect (A suspect aspect). 98
Orbital lymphoom. (Orbital lymphomas). 98
Vergelijking Mullerectomie bij levator desinsertie d.m.v. posterieure versus anterieure benadering. (Comparison of Mullerectomy associated to levator disinsertion throught an anterior or posterior approach). 93
Ultrasonographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy. 93
Embrional rhabdomiosarcoma of the orbit. 91
Kanker van de oog en oogkas. [Cancer of the eye and orbit]. 91
Orbitopatia tiroide correlata. [Thyroid Related Orbitopathy] 90
null 87
Totale 13.506
Categoria #
all - tutte 36.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021385 0 0 0 0 0 14 69 73 43 44 42 100
2021/2022944 9 94 12 60 191 133 14 32 47 13 36 303
2022/20231.177 129 87 70 87 150 194 6 103 205 9 127 10
2023/20241.336 250 213 179 109 190 210 9 24 25 9 27 91
2024/20253.938 13 124 18 120 323 287 283 196 273 421 268 1.612
2025/20261.562 155 461 289 153 216 288 0 0 0 0 0 0
Totale 14.344